Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Bio-Protocol|September 9, 2022
Generation of a Human Conditionally Immortalized Cell-based Multicellular Spheroidal Blood-Brain Barrier Model for Permeability Evaluation of MacromoleculesRyuto Isogai, Hanae Morio, Ayaka Okamoto, et al.Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|July 25, 2019
Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5Toshiro Niwa, Kanae Narita, Ayaka Okamoto, et al.The Journal of Gene Medicine|October 10, 2013
Polycation liposomes as a vector for potential intracellular delivery of microRNAHidenori Ando, Ayaka Okamoto, Masafumi Yokota, et al.International Journal of Pharmaceutics|August 16, 2019
Key determinants of siRNA delivery mediated by unique pH-responsive lipid-based liposomesMariko Sako, Furan Song, Ayaka Okamoto, et al.Archives of Biochemistry and Biophysics|February 1, 2020
Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamiliesToshiro Niwa, Ayaka Okamoto, Kanae Narita, et al.Journal of Clinical Medicine|January 23, 2016
Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood FlowAyaka Okamoto, Tomohiro Asai, Sho Ryu, et al.Biochemical and Biophysical Research Communications|May 24, 2014
Antibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGFAyaka Okamoto, Tomohiro Asai, Hiroki Kato, et al.Biological & Pharmaceutical Bulletin|June 4, 2019
Design of a Novel PEGylated Liposomal Vector for Systemic Delivery of siRNA to Solid TumorsFuran Song, Naoyuki Sakurai, Ayaka Okamoto, et al.Molecular Pharmaceutics|March 6, 2018
Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast CancerAyaka Okamoto, Tomohiro Asai, Yusuke Hirai, et al.The Journal of Gene Medicine|December 15, 2012
Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapyHidenori Ando, Ayaka Okamoto, Masafumi Yokota, et al.Pageof 3